Unvaccinated students not allowed to attend Newton Public Schools starting this fall
Students who are not up to date on their vaccinations will not be allowed back inside of Newton classrooms this fall, according to Anna Nolin, the superintendent of public schools.
In a memo sent to the Newton School Committee last week, Nolin says the district's decision to reinforce state vaccination requirements comes after a recent chickenpox outbreak in the district.
182 unvaccinated students
A meeting with Newton Health and Human Services and the city's nursing division also revealed 182 students have been attending school without the proper immunizations since the COVID-19 pandemic.
Officials say 42 of them are not fully vaccinated against measles, which raises concern for medical professionals like Dr. Shira Doron. The infectious disease physician at Tufts University is worried about the spread of measles amid a growing number of cases across the country.
"You could have someone travel, you could have someone interact with a traveler who's been to an area of the country or of the world where measles is being actively transmitted bringing it back and causing an ongoing outbreak," she said.
Her concern comes after a report earlier this month revealed that a tourist with measles visited Boston, potentially exposing people at the Museum of Fine Arts Boston, the Westin Boston Seaport District hotel, and Logan Airport.
That's exactly why Corrie Howe, a resident of Newton agrees with the vaccine reinforcement. "Being a pediatric nurse, I feel vaccinations are really important especially for the overall community health," she said.
Jennifer Miller echoed that sentiment saying, "I wouldn't want to have my children exposed to other children who aren't vaccinated," she said.
However, Desiree Silva is a bit more hesitant when it comes to vaccines. She called the schools strict policy "absurd" saying, "I think it should be the parent's choice. I don't think anyone should be forced to get vaccinated."
Exemptions allowed
Massachusetts allows families to request an exemption from the state vaccination mandate if a doctor says it's not in the child's best interest or if it conflicts with religious beliefs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Dietitian Who Lost 60 Pounds With GLP-1 Drug Reveals Foods to Avoid and Prioritize
Jennifer Lynn-Pullman is a certified specialist in obesity and weight management, so she was frustrated when her own weight kept rising over the years. 'I had struggled with my weight for a long time. My whole family struggles as well, so it's very genetic,' Lynn-Pullman, 48, a registered dietitian and manager of clinical dietetics for Vida Health, tells "And of course, in your 40s with perimenopause, it doesn't get any easier.' Lynn-Pullman, who lives in suburban Philadelphia, was alarmed when her cholesterol went up for the first time two years ago and her A1C — a measure of blood sugar — was trending up. At 5 feet, 6 inches tall, she weighed 200 pounds and worried she was on track to develop Type 2 diabetes in her 50s like her parents. Her doctor prescribed Wegovy, the version of Ozempic approved for weight loss. It's part of the GLP-1 class of medications that mimic a hormone the body produces after eating to decrease appetite and help the body manage insulin production. After starting the drug in 2023, Lynn-Pullman lost 60 pounds in 10 months and has maintained that weight for more than a year. Like many patients, she experienced side effects and had to figure out which foods to avoid on a GLP-1 and how to prevent muscle loss. Here are her tips for eating on a GLP-1 based on her own experience: Lynn-Pullman had side effects for the first six months, usually when her medication dosage was increased. GLP-1 drugs slow stomach emptying, one of the reasons patients can experience uncomfortable symptoms. Nausea and vomiting are some of the most common side effects. For nausea, Lynn-Pullman prefers to use ginger gum. She also prepares easy to digest foods like a smoothie, soup and crackers that aren't too heavy for her stomach. Vomiting is usually due to eating too much or consuming high-fat foods, so she advises eating smaller meals, not eating too fast and avoiding greasy foods. 'Fat just stays in your stomach longer,' she says. 'With someone whose stomach is emptying much slower, it causes more of an upset.' Lynn-Pullman realized her vomiting episodes were caused by high-fiber muffins she was eating to help ease constipation. Once she cut them out, the problem stopped. The dietitian decided to treat herself like her bariatric surgery patients. 'I realized that because Wegovy causes such an increased level of satiety and such a long level of fullness, that it was very similar to those patients,' she says. Lynn-Pullman eats very small frequent meals she sometimes calls 'eating episodes.' She eats a higher-protein diet to help combat any muscle loss. She has protein every time she eats, consuming that food first, then fruits and vegetables. Any starchy food is last, if there's even room for it. Since liquid fills up the stomach, she suggests not drinking beverages with meals to get enough food in, then hydrating between meals. Here's her typical daily menu: Breakfast: A protein shake, cereal with fiber and ultrafiltered milk, which contains more protein than regular milk. Lunch: A turkey sandwich or salad topped with chicken. Dinner: Chicken or salmon with a vegetable. She occasionally eats rice or pasta on the side, but it fills her up too much, so she usually skips it. Snacks: An apple with peanut butter or nuts with a piece of fruit. Lynn-Pullman always loved sweets, noting she couldn't pass up a cookie or a piece of chocolate, especially in the afternoon. But after she began using Wegovy, she stopped craving sugar. 'It was the most miraculous thing,' Lynn-Pullman recalls. 'The food noise, that inner voice saying, 'Go get something sweet' — it vanished.' Today, she occasionally eats dark chocolate or might split a dessert with her husband if she goes out to dinner, but mostly skips sweets. When it comes to alcohol, she has a drink 'once in a blue moon if she goes to a party." 'The thing that I worry about is being nauseous or even feeling dehydrated the next day,' Lynn-Pullman says. 'We usually suggest that patients refrain from it just because of all of those potential side effects.' The dietitian works out three times a week, focusing on weight training to minimize muscle loss. Three months after starting Wegovy, Lynn-Pullman noticed she was cold all the time, even in the August summer heat. She began journaling her food intake and discovered she was eating only 800 calories a day, with very little protein. 'It's easy to do on a GLP-1 because you don't feel hungry and you fill up quickly,' Lynn-Pullman says. 'We worry about malnutrition, we worry about people not getting enough nutrients.' When she started eating more protein and calories, her symptoms went away quickly. That's why it's important to work with a dietitian and report symptoms like feeling cold, tired or exhausted, or noticing hair loss — potential symptoms of eating too little, Lynn-Pullman notes. This article was originally published on
Yahoo
38 minutes ago
- Yahoo
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
The healthcare sector offers an abundance of high-growth investment opportunities. Companies leveraging artificial intelligence and genomic medicine are delivering innovative therapies with significant potential. Small-cap and under-the-radar stocks with strong growth possibilities merit closer investor attention. 10 stocks we like better than TransMedics Group › There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving. Investors stand to benefit as healthcare leaders and emerging players address the needs of an aging global population and the rising prevalence of chronic diseases. Here are 10 under-the-radar healthcare stocks that could be great buys for your portfolio. Certara (NASDAQ: CERT) is poised to capitalize on the transformation in medicine driven by artificial intelligence (AI), providing bio-simulation software and services that accelerate drug development. The company plays a crucial role in the pharmaceutical industry. Over 90% of all novel drugs approved by the Food and Drug Administration (FDA) since 2014 have leveraged its technology. Its AI-driven solutions enhance research and development (R&D), enabling faster and more precise drug development. Certara deserves a closer look by investors seeking to tap into the AI-driven healthcare transformation. Beam Therapeutics (NASDAQ: BEAM) is a clinical-stage biotech pioneering precision-based gene editing therapies for genetic diseases, including sickle cell disease. Its innovative technology enables precise single-nucleotide DNA changes, potentially offering a safer alternative to traditional CRISPR genetic engineering. Beam has reported early success in gene correction, with its lead candidate, BEAM-101, in phase 1/2 trials for sickle cell disease. While the company still has a lot to prove, its differentiated approach and clinical progress position it for remarkable growth in the long term. Inspire Medical Systems (NYSE: INSP) develops implantable neurostimulation devices for obstructive sleep apnea, offering its FDA-approved Inspire therapy as a noninvasive alternative to CPAP machines. In its first quarter (the period ended March 31), revenue surged 23% year over year to $201 million, driven by growing U.S. adoption and new international approvals. With increasing demand for sleep apnea treatment, Inspire has a significant opportunity to capture market share. Insulet (NASDAQ: PODD) specializes in tubeless insulin pump technology. Its Omnipod system simplifies diabetes management for Type 1 and insulin-dependent Type 2 patients globally, offering convenience and improved outcomes. With a 2025 revenue growth target of 19% to 22%, the company is poised for continued expansion, particularly in underpenetrated international markets. Insulet's strong growth trajectory positions it to reward shareholders further. Krystal Biotech (NASDAQ: KRYS) focuses on rare skin diseases. Its FDA-approved gene therapy, Vyjuvek, for dystrophic epidermolysis bullosa (fragile skin that blisters easily) is expected to approach $400 million in revenue this year, solidifying its position as a best-in-class treatment. Vyjuvek's success validates Krystal's R&D, bolstering confidence in its pipeline and unlocking added market potential. LifeMD (NASDAQ: LFMD) operates a telehealth platform providing specialized virtual care in weight loss, men's health, and dermatology. A partnership with Novo Nordisk to offer Wegovy, a leading GLP-1 treatment, has driven impressive growth, with first-quarter revenue surging 49% year over year for the period ended March 31. LifeMD could expand its growing user base into a comprehensive health management ecosystem to fuel growth and solidify its telehealth leadership. Option Care Health (NASDAQ: OPCH) is the leading U.S. provider of home and alternative-site infusion services, delivering crucial therapies for chronic and acute conditions like cancer, immune deficiencies, and infections. As the healthcare industry shifts toward more personalized and cost-effective care, Option Care Health is in position to capitalize on the strong demand, with its extensive network and high-quality services. Tempus AI (NASDAQ: TEM) harnesses artificial intelligence to advance precision medicine, using its collection of clinical and molecular data from more than 40 million patients to power diagnostics in oncology, cardiology, and beyond. The company projects its revenue to climb by more than 80% this year, to about $1.3 billion. Tempus AI's scalable platform and extensive data ecosystem present substantial opportunities for expansion and impact in personalized healthcare. TransMedics Group (NASDAQ: TMDX) has revolutionized organ transplantation with its Organ Care System (OCS), the only FDA-approved device for heart, lung, and liver transplants that extends organ preservation time. The company's projected revenue growth of 30% this year underscores the strong momentum in a global expansion opportunity. Veeva Systems (NYSE: VEEV) offers cloud-based software that streamlines clinical, regulatory, and commercial processes for life sciences companies. Serving over 1,000 customers, including major pharmaceutical companies and emerging biotechs, Veeva's platform is well positioned to capitalize on the industry's increasing reliance on digital solutions for innovation and compliance. Before you buy stock in TransMedics Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and TransMedics Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Dan Victor has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Beam Therapeutics, Inspire Medical Systems, TransMedics Group, and Veeva Systems. The Motley Fool recommends Insulet, Krystal Biotech, and Novo Nordisk. The Motley Fool has a disclosure policy. 10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential was originally published by The Motley Fool
Hamilton Spectator
an hour ago
- Hamilton Spectator
How to protect yourself from ticks year-round
WASHINGTON (AP) — Ticks can be active in any season and it's important to check for and remove the bloodsuckers as quickly as possible — especially after you've been outside hiking, gardening or enjoying nature. 'Humans are outside more in summer so we hear about more tick infections ,' said Sam Telford, an infectious diseases expert at Tufts University. But he urges caution year-round because 'every season is tick season.' While tick populations vary a lot regionally, some Northeastern states including Maine, Massachusetts and Rhode Island are seeing 'above average' numbers of American dog ticks this year, said Telford. And New York state is seeing a higher number of reported deer tick bites this year than last year, said Saravanan Thangamani, who studies tick-borne diseases at SUNY Upstate Medical University. How ticks can spread disease Ticks, like mosquitos, need to feed on blood. But instead of a quick prick, they are slow feeders – with hooked mouth parts that attach into the skin of deer, rabbits, dogs and people. There are many different species of ticks found globally and only some spread germs that can make people sick. A main worry is blacklegged ticks, also called deer ticks, which can spread Lyme disease. Once found mainly in New England and pockets of the Midwest, the ticks are now present over a wider range. A tick bite doesn't always lead to illness. 'If you remove a tick within 24 hours of attachment, it's fairly unlikely that you will get infected,' said Telford. How to check for ticks Ticks are usually found low to the ground, in leaf litter or grassy areas. Check your clothing for ticks and do a full-body check including under the arms and behind ears, knees and hair. 'If you're out all day long, try to do a quick check for ticks every few hours,' said Bobbi Pritt at the Mayo Clinic. 'When you go back inside, take a shower. That will wash off any unattached ticks, and you're also more likely to spot any other ticks.' Use tweezers to remove the tick and grasp it as close to the skin as possible to pull from the head. If you don't have them handy, you can also use your fingernails, the edge of a credit card or any semi-sharp object. How to keep ticks away The best approach is to minimize tick exposure altogether. Bug sprays containing ingredients such as DEET can be sprayed on exposed skin to ward off ticks and mosquitos, said Telford. Wear long sleeves and pants, and you can also spray clothing with repellents containing permethrin, a chemical similar to a natural ingredient in chrysanthemums that makes ticks avoid the flowers. Protect your pets from ticks Don't forget to pay attention to outdoor pets. Medications can prevent fleas and ticks from attaching to a dog's skin. But it's still a good idea to check the fur after being outside. 'Wherever pets can't easily groom themselves, that's where the ticks will be – on the ears, around the muzzle area, under the collar, between the toes,' said Thangamani. Dogs and cats roaming outdoors can also bring ticks into the house. 'If pets bring ticks in, a tick can live in the house for months until it finds its next blood meal,' which could be another household member, he said. What to do after a tick bite After removing the tick, keep an eye on the skin around the bite. If a rash or flu-like symptoms appear within several days or weeks, see a doctor. The Centers for Disease Control and Prevention does not recommend tick testing because results may not be reliable. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
